JOHANNA CLEMENS: Open Payments
NPI 1063800886 · GRANTS PASS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 13 payments from 9 companies in 2025. Trend: 2023 $173 · 2024 $283 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $47 |
| Ascendis Pharma Endocrinology Inc | 2 | $43 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Astellas Pharma US Inc | 2 | $32 |
| ABBVIE INC. | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| Lilly USA, LLC | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: Yorvipath, REXULTI, Veozah, UBRELVY, Rybelsus, Ozempic, INSPIRE, The Cologuard Plus Collection Kit.
Industry payments across OR — which companies pay providers there.
